Do you want to read an article? Please log in or register.
Expanded Field OCTA Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy
Cardiovascular Risk and Diseases
Related content
Cardiovascular Risk and Diseases
The association between stress-induced hyperglycemia ratio and cardiovascular events as well as all-cause mortality in patients with chronic kidney disease and diabetic nephropathy
Cardiovasc Diabetol
Cao B, Guo Z, Li DT, Zhao LY, Wang Z, Gao YB, Wang YX
doi: 10.1186/s12933-025-02610-1
COMMENTED
Cardiovascular Risk and Diseases
The Frequency of Undiagnosed Celiac Disease in Youth with Type 1 Diabetes and Its Association with Diabetic Retinopathy: The SEARCH for Diabetes in Youth Study
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Pediatr Diabetes
Brady RP, Jensen ET, Rigdon J, Crimmins NA, Mallon D, Dolan LM, Imperatore G, Kahkoska AR, Mottl AK, Honor A, Pettitt DJ, Merjaneh L, Dabelea D, Shah AS
doi: 10.1155/2023/9038795
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
Cardiovascular Risk and Diseases
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease
Diabetes Obes Metab
Lee DY, Moon JS, Jung I, Chung SM, Park SY, Yu JH, Seo JA, Han KD, Kim NH
doi: 10.1111/dom.16165
Cardiovascular Risk and Diseases
Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study
Diabetes Obes Metab
Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J
doi: 10.1111/dom.70214
Heart, Artery and Coronary Diseases
Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study
Lancet Diabetes Endocrinol
Gong JY, Morton JI, Chen L, Sacre JW, Carstensen B, Gregg EW, Pavkov ME, Arffman M, Booth GL, Ter Braake JG, Chu LM, Fleetwood K, Fosse-Edorh S, Garbuviene M, Guion M, Ha KH, Kaul P, Ke C, Keskimäki I, Kim DJ, Laurberg T, Salim A, Støvring H, Vos RC, Wild SH, Fourlanos S, Shaw JE, Magliano DJ
doi: 10.1016/S2213-8587(25)00265-7
Heart, Artery and Coronary Diseases
Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study
Atherosclerosis
Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM
doi: 10.1016/j.atherosclerosis.2025.120390
Cardiovascular Risk and Diseases
Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease
Am J Gastroenterol
Barritt AS 4th, Tapper EB, Newsome PN, Gazis D, Morris H, Mospan AR, Perez AD, Kim Y, Neuschwander-Tetri BA, Loomba R, Sanyal A, TARGET-NASH Investigators
doi: 10.14309/ajg.0000000000003595
Cardiovascular Risk and Diseases
Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort
Cardiovasc Diabetol
Salle L, Julla JB, Fagherazzi G, Gourdy P, Bezerra Parente E, Hanaire H, Tatulashvili S, Disse E, Franc S, Hadjadj S, Larger E, Sanz C, Vaduva P, Valero R, Bonnefond A, Cosson E, Aguayo GA, Riveline JP, SFDT1 group
doi: 10.1186/s12933-025-02789-3